Vaccines

Committed to developing novel vaccines against major infectious diseases and public health threats worldwide

Patronus Biotech
Technology Platform

Unique U-VLP™ (Universal Virus-Like Particles) platform
Breaks through the limitations of traditional VLP technology in pathogen types

  • Stable and high yield:

    Breaks bottlenecks of traditional VLP manufacturing technology

  • Broad spectrum:

    Can be used for rapid development of a wide range of pathogenic vaccines, including emergency products such as COVID vaccine

  • Stronger efficacy:

    Particle presentation improves the immunogenicity of otherwise poorly immunogenic protein antigens, together with steric presentation promotes conserved epitopes recognition thus higher broadly neutralising antibody titers

Commercial plant of international-standard

Pilot workshop

Manufacture workshop

Yantai

Pilot workshop
  • Located in the 1# building of Shandong International Biotechnology Park
  • It passed the EU QP certification in October 2021
Manufacture workshop
  • Six 200L GMP production lines with an annual production capacity of 1 billion doses
  • Equipped with microbiology workshop, CHO cell workshop, formulation filling workshop, QA, QC, and cold chain storage